Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3)

Olivier Bruyère, Cyrus Cooper, Nigel Arden, Jaime Branco, Maria Luisa Brandi, Gabriel Herrero-Beaumont, Francis Berenbaum, Elaine Dennison, Jean Pierre Devogelaer, Marc Hochberg, John Kanis, Andrea Laslop, Tim McAlindon, Susanne Reiter, Pascal Richette, René Rizzoli, Jean Yves Reginster

Research output: Contribution to journalComment/debatepeer-review

2 Citations (Scopus)

Abstract

In the Original publication the affiliation for J. Kanis was incorrectly published. This previously read: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK. Should read: Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.

Original languageEnglish
Pages (from-to)411
Number of pages1
JournalDrugs & Aging
Volume34
Issue number5
DOIs
Publication statusPublished - 1 May 2017

Fingerprint

Dive into the research topics of 'Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3)'. Together they form a unique fingerprint.

Cite this